CR Labs has made an AU$500,000 investment in a high-tech lens testing facility in Melbourne – the first of its kind in Australia.
Eye disorders are one of the most common long-term health problems experienced by Australian children, with an economic impact of AU$624 million per year,
In what has been described as “an incredible milestone for the prevention of diabetes-related eye complications”, the KeepSight eye check reminder program has registered
As part of its preparation to progress Sozinibercept (OPT-302) – a new drug for neovascular age-related macular degeneration (nAMD) – towards registration and launch,
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
